Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Children's Hospital, Genethon get FDA OK for gene therapy trial

July 22, 2011 8:41 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Children's Hospital Boston has won approval from the U.S. Food and Drug Administration for a gene therapy trial in conjunction with French biotech Genethon to treat the rare immunodeficiency known as Wiskott-Aldrich syndrome.

Ortho Clinical Diagnostics Launches VITROS® 4600 Chemistry System for Mid- to High-Volume Laboratories

July 22, 2011 7:44 am | by Bio-Medicine.Org | News | Comments

RARITAN, N.J., July 22, 2011 /- Ortho Clinical Diagnostics (OCD) today announced the launch of the VITROS® 4600 Chemistry System, a state-of-the-art analyzer that delivers high-quality, reliable test results for mid- to high-volume laboratories using the same core technologies that...

Merz Pharmaceuticals Commends The Benign Essential Blepharospasm Research Foundation On 30 Years Of Community Support

July 22, 2011 7:40 am | by Bio-Medicine.Org | News | Comments

GREENSBORO, N.C., July 22, 2011 /- Merz Pharmaceuticals, LLC, commends the Benign Essential Blepharospasm Research Foundation (BEBRF) for 30 years of dedication to increasing awareness of blepharospasm, a neurological disorder that causes abnormal, involuntary spasms of the muscles around...

Advertisement

Elekta European Users' Conference Attracts Top Minds in Cancer Management

July 22, 2011 7:40 am | by Bio-Medicine.Org | News | Comments

STOCKHOLM, July 22, 2011 /- Elekta users from Europe, Asia, the Middle East, North America and Africa converged on Hotel Hohe Dune in Warnemunde, Germany June 16-19 to participate in Elekta's fifth European Users' Conference. Approximately 390 clinicians and scientists attended 31...

Dynatronics Appoints Bryan D. Alsop Vice President of Information Technology

July 22, 2011 4:40 am | by Bio-Medicine.Org | News | Comments

SALT LAKE CITY, July 22, 2011 /- Dynatronics Corporation (Nasdaq: DYNT ) today announced the appointment of Bryan D. Alsop as its new vice president of information technology. "We are pleased to add Bryan to our management team," said Kelvyn Cullimore Jr., chairman and president of...

Ortho Clinical Diagnostics Launches VITROS 4600® Chemistry System for Mid- to High-Volume Laboratories

July 22, 2011 4:39 am | by Bio-Medicine.Org | News | Comments

RARITAN, N.J., July 22, 2011 /- Ortho Clinical Diagnostics (OCD) today announced the launch of the VITROS® 4600 Chemistry System, a state-of-the-art analyzer that delivers high-quality, reliable test results for mid- to high-volume laboratories using the same core technologies that...

FDA Clears Siemens Software for Cerebral Blood Flow Assessment

July 22, 2011 4:35 am | by Diagnostic Imaging | News | Comments

Siemens Healthcare has received FDA 501(k) marketing clearance for a software package that helps in the assessment of cerebral blood flow during interventional procedures.

CT Bests Barium in Adult Celiac Disease Diagnosis

July 22, 2011 4:34 am | by Diagnostic Imaging | News | Comments

Improvements in computed tomography (CT) resolution of the small bowel, colon, and mesenteric lymph nodes have pushed CT scans ahead of traditional barium examinations in the diagnosis of celiac disease, according to a new study in the journal RadioGraphics.

Advertisement

Taiho Pharmaceutical Announces Results of Randomized Phase II Clinical Trial with Novel Antitumor Agent TAS-102

July 22, 2011 1:39 am | by Bio-Medicine.Org | News | Comments

TOKYO, July 22, 2011 /- Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President: Toru Usami) announced on July 22 the results of a randomized, Phase II clinical trial for the novel oral nucleoside antitumor agent TAS-102 under development by the company for metastatic colorectal cancer, at...

3SBio Inc. Schedules Unaudited Second Quarter 2011 Results

July 22, 2011 1:39 am | by Bio-Medicine.Org | News | Comments

SHENYANG, China, July 22, 2011 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX ) ("3SBio" or "the Company"), a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it will release...

£20k Raised For Yorkshire Hospices - Search Laboratory's Lycra Lads' Cycle To The Finish Line

July 21, 2011 11:39 pm | by RealWire | News | Comments

With the original target of £10,000 smashed a week before the Coast-to-Coast bike ride was due to take place, the team decided to raise their target and now have almost £20,000 to split between the two deserving charities; St Gemma's Hospice, Leeds and St Leonard's Hospice,...

Multaq (dronedarone): Drug Safety Communication - Increased Risk of Death or Serious Cardiovascular Events

July 21, 2011 6:30 pm | by U.S. Food & Drug Administration | News | Comments

FDA reviewing data from a clinical trial.

Boston Scientific's Credit Rating Raised to Investment Grade

July 21, 2011 11:48 am | by Boston Scientific | News | Comments

NATICK, Mass., July 21, 2011 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) announces that Fitch Ratings has upgraded the Company's corporate credit rating to an investment grade rating, BBB-, with a stable outlook

Advertisement

MedSolutions Introduces Spine Surgery Management Program

July 21, 2011 9:48 am | by Bio-Medicine.Org | News | Comments

FRANKLIN, Tenn., July 21, 2011 /- MedSolutions , a leading provider of medical management services, today announced the launch of its Lumbar Spine Surgery Management Program for ensuring the clinical appropriateness of spine surgery for individuals suffering from lower back pain, spinal...

Thermo Fisher licenses biomarker assays to Alere

July 21, 2011 9:46 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Life sciences equipment supplier Thermo Fisher Scientific Inc. today announced that it has signed a license agreement with Alere Inc. to add its BRAHMS biomarker assays to Alere's point-of-care Triage platform.

Cardiac Science Expands Device Connectivity Solutions

July 21, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

BOTHELL, Wash., July 21, 2011 /- Cardiac Science Corporation , a global leader in automated external defibrillators (AEDs) and diagnostic cardiac monitoring devices that connect to electronic medical records (EMRs) and hospital information systems, announced today the new capability of...

Oral Osteoporosis Drugs (bisphosphonates): Drug Safety Communication - Potential Increased Risk of Esophageal Cancer

July 21, 2011 9:31 am | by U.S. Food & Drug Administration | News | Comments

FDA is reviewing data from published studies to evaluate risk of cancer of the esophagus.

Mettler-Toledo International Inc. to Host Second-Quarter 2011 Earnings Conference Call

July 21, 2011 6:40 am | by Bio-Medicine.Org | News | Comments

COLUMBUS, Ohio, July 21, 2011 /- Mettler-Toledo International Inc. (NYSE: MTD ) today announced it will host a conference call to discuss the Company's second-quarter results on Thursday, July 28, 2011 at 5:00 p.m. Eastern Time. To hear a live webcast of the call, visit...

Omnicell to Release Second Quarter 2011 Earnings Results on July 28

July 21, 2011 6:40 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., July 21, 2011 /- Omnicell, Inc. (NASDAQ: OMCL ), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, will hold a conference call Thursday, July 28, to discuss the Company’s Second Quarter 2011...

Mindray to Report Second Quarter 2011 Financial Results on August 8, 2011

July 21, 2011 6:40 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, July 21, 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR ), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will report its financial results for the second quarter ended June 30,...

Motorika Appoints Patterson Medical as its Distributor for North America

July 21, 2011 6:39 am | by Bio-Medicine.Org | News | Comments

TRUSSVILLE, Ala., July 21, 2011 /- Motorika, a leader in the development of robotic devices for the rehabilitation of the upper and lower body extremities, has appointed Patterson Medical, the rehabilitation supply and equipment unit of Patterson Companies, Inc., as the exclusive...

Cephalon Receives FDA Approval for Risk Evaluation and Mitigation Strategy for FENTORA and ACTIQ

July 21, 2011 6:39 am | by Bio-Medicine.Org | News | Comments

FRAZER, Pa., July 21, 2011 /- Cephalon, Inc. (Nasdaq: CEPH ) announced today that the U.S. Food and Drug Administration (FDA) approved the Risk Evaluation and Mitigation Strategy (REMS) for FENTORA® (fentanyl buccal tablet) [C-II] and ACTIQ® (oral transmucosal fentanyl citrate)...

Quanterix Digital Immunoassay for Prostate Specific Antigen Improves Analytical Performance

July 21, 2011 6:38 am | by Bio-Medicine.Org | News | Comments

CAMBRIDGE, Mass., July 21, 2011 /- Quanterix Corporation, an in-vitro diagnostics (IVD) company providing life science researchers and IVD labs single molecule technology with unprecedented sensitivity and precision, announced that the analytical performance of AccuPSA™, a...

Unique Device Identification (UDI) for Postmarket Surveillance and Enforcement Public Workshop, September 12-13, 2011

July 21, 2011 5:31 am | by U.S. Food & Drug Administration | News | Comments

The Food and Drug Administration is holding a public workshop on the adoption, implementation, and use of unique device identifiers (UDIs) in various health-related electronic data systems. The purpose of this workshop is to engage multiple...

Lilly Reports Second-Quarter 2011 Results

July 21, 2011 3:46 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, July 21, 2011 /- Second-quarter 2011 revenue grew 9 percent to $6.253 billion due to increased demand and favorable exchange rates. Q2 expense growth driven primarily by marketing efforts to support new launches, restructuring charge and exchange rates. R&D investments...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading